Analysts Expect Safeguard Scientifics, Inc (SFE) to Post -$0.94 Earnings Per Share

Share on StockTwits

Brokerages forecast that Safeguard Scientifics, Inc (NYSE:SFE) will announce earnings per share (EPS) of ($0.94) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings of ($0.91) per share in the same quarter last year, which suggests a negative year-over-year growth rate of 3.3%. The business is scheduled to announce its next quarterly earnings report on Thursday, March 7th.

According to Zacks, analysts expect that Safeguard Scientifics will report full year earnings of ($0.89) per share for the current year. For the next fiscal year, analysts anticipate that the firm will report earnings of ($3.02) per share. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings data on Thursday, October 25th. The asset manager reported $1.56 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.61 by ($0.05).

A number of research analysts recently issued reports on the company. Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a research report on Wednesday, September 26th. ValuEngine lowered Safeguard Scientifics from a “hold” rating to a “sell” rating in a research report on Monday, July 30th. Finally, First Analysis reiterated an “equal weight” rating and set a $25.00 price target on shares of Safeguard Scientifics in a research report on Friday, July 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. Safeguard Scientifics has an average rating of “Hold” and a consensus price target of $18.13.

A number of hedge funds have recently made changes to their positions in the business. First Manhattan Co. boosted its position in Safeguard Scientifics by 0.7% during the 3rd quarter. First Manhattan Co. now owns 1,575,296 shares of the asset manager’s stock worth $14,729,000 after acquiring an additional 11,079 shares during the period. Janus Henderson Group PLC boosted its position in Safeguard Scientifics by 11.8% during the 3rd quarter. Janus Henderson Group PLC now owns 474,347 shares of the asset manager’s stock worth $4,423,000 after acquiring an additional 49,960 shares during the period. Prescott Group Capital Management L.L.C. boosted its position in Safeguard Scientifics by 313.0% during the 3rd quarter. Prescott Group Capital Management L.L.C. now owns 453,652 shares of the asset manager’s stock worth $4,242,000 after acquiring an additional 343,805 shares during the period. Renaissance Technologies LLC boosted its position in Safeguard Scientifics by 68.1% during the 2nd quarter. Renaissance Technologies LLC now owns 270,437 shares of the asset manager’s stock worth $3,462,000 after acquiring an additional 109,556 shares during the period. Finally, Northern Trust Corp boosted its position in Safeguard Scientifics by 4.8% during the 2nd quarter. Northern Trust Corp now owns 257,886 shares of the asset manager’s stock worth $3,301,000 after acquiring an additional 11,705 shares during the period. Institutional investors own 72.38% of the company’s stock.

NYSE:SFE traded down $0.12 during midday trading on Monday, reaching $8.21. 58,400 shares of the company traded hands, compared to its average volume of 100,895. Safeguard Scientifics has a twelve month low of $8.20 and a twelve month high of $13.95. The firm has a market capitalization of $171.99 million, a P/E ratio of -1.89 and a beta of 1.18. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.58 and a quick ratio of 2.58.

About Safeguard Scientifics

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Read More: Growth Stocks, What They Are, What They Are Not

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply